DD
Therapeutic Areas
BioVaxys Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Maveropepimut-S (MVP-S) | Recurrent Ovarian Cancer | Phase 2B |
| DPX-formulated Products | Non-Muscle Invasive Bladder Cancer (NMIBC) | Phase 1 |
| Haptenized Viral Vaccines | Viral Infections | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Maveropepimut-S (MVP-S) | Recurrent Ovarian Cancer | Phase 2B |
| DPX-formulated Products | Non-Muscle Invasive Bladder Cancer (NMIBC) | Phase 1 |
| Haptenized Viral Vaccines | Viral Infections | Preclinical |